BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10208295)

  • 1. MAO inhibitors and oxidant stress in aging brain tissue.
    Alper G; Girgin FK; Ozgönül M; Menteş G; Ersöz B
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):247-52. PubMed ID: 10208295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of MAO-B inhibition against ischemia-induced oxidative stress in the rat brain. Comparison with a rational antioxidant.
    Seif-El-Nasr M; Atia AS; Abdelsalam RM
    Arzneimittelforschung; 2008; 58(4):160-7. PubMed ID: 18540477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of I-deprenyl and gliclazide on oxidant stress/antioxidant status and dna damage in a diabetic rat model.
    Alper G; Irer S; Duman E; Caglayan O; Yilmaz C
    Endocr Res; 2005; 31(3):199-212. PubMed ID: 16392622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy.
    Kitani K; Minami C; Yamamoto T; Maruyama W; Kanai S; Ivy GO; Carrillo MC
    Ann N Y Acad Sci; 2001 Apr; 928():248-60. PubMed ID: 11795516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the MAO-B inhibitor, MDL72974, on superoxide dismutase activity and lipid peroxidation levels in the mouse brain.
    Thiffault C; Quirion R; Poirier J
    Synapse; 1998 Mar; 28(3):208-11. PubMed ID: 9488505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dehydroepiandrosterone (DHEA) on monoamine oxidase activity, lipid peroxidation and lipofuscin accumulation in aging rat brain regions.
    Kumar P; Taha A; Sharma D; Kale RK; Baquer NZ
    Biogerontology; 2008 Aug; 9(4):235-46. PubMed ID: 18307051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
    Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why (--)deprenyl prolongs survivals of experimental animals: increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects.
    Kitani K; Minami C; Isobe K; Maehara K; Kanai S; Ivy GO; Carrillo MC
    Mech Ageing Dev; 2002 Apr; 123(8):1087-100. PubMed ID: 12044958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoflavones prevent oxidative stress and inhibit the activity of the enzyme monoamine oxidase in vitro.
    da Silva Schmitz I; Schaffer LF; Busanello A; de Freitas CM; Fachinetto R; Peroza LR
    Mol Biol Rep; 2019 Apr; 46(2):2285-2292. PubMed ID: 30756334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
    Thiffault C; Quirion R; Poirier J
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):127-36. PubMed ID: 9387872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is brain superoxide dismutase activity increased following chronic treatment with 1-deprenyl?
    Lai CT; Zuo DM; Yu PH
    J Neural Transm Suppl; 1994; 41():221-9. PubMed ID: 7931229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN; Harik SI
    J Neurochem; 1987 Nov; 49(5):1589-94. PubMed ID: 3117975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial antioxidant status and oxidative stress after combined action of exercise training and ethanol in two different age groups of male albino rats.
    Pushpalatha K; Nishanth K; Sathyavelu Reddy K
    Acta Biol Hung; 2007 Jun; 58(2):173-85. PubMed ID: 17585507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprenyl and the relationship between its effects on spatial memory, oxidant stress and hippocampal neurons in aged male rats.
    Kiray M; Bagriyanik HA; Pekcetin C; Ergur BU; Uysal N; Ozyurt D; Buldan Z
    Physiol Res; 2006; 55(2):205-212. PubMed ID: 15910165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant-like effect of the saponins part of ethanol extract from SHF.
    Liang Y; Yang X; Zhang X; Duan H; Jin M; Sun Y; Yuan H; Li J; Qi Y; Qiao W
    J Ethnopharmacol; 2016 Sep; 191():307-314. PubMed ID: 27321411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.